[1]
Aung, T.H. 2022. Proximicin A-C as prospective HER2-positive and negative breast cancer drugs: Molecular docking and in silico ADME modeling. IPS Journal of Molecular Docking Simulations. 1, 1 (May 2022), 1–11. DOI:https://doi.org/10.54117/ijmds.v1i1.9.